Literature DB >> 25499288

FOLFOXIRI and bevacizumab in metastatic colorectal cancer.

Ahmadur Rahman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25499288     DOI： 10.1016/S1470-2045(14)71112-X

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  1 in total

1.  Cetuximab versus bevacizumab maintenance following prior 8-cycle modified FOLFOXIRI plus cetuximab in Asian postmenopausal women with treatment-naive KRAS and BRAF wild-type metastatic colorectal cancer.

Authors:  Baomin Chen; Donghua Zheng; Weiguang Yu; Cuiping Huang; Junxing Ye; Guowei Han; Jintao Zhuang
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.